Interventional Cardiology
PERCUTANEOUS CORONARY INTERVENTION ( PCI )
Cardiac Cath Cases ( FY18 ) >
2,000
Interventional cardiologists on the medical staff of Baylor Scott & White Heart and Vascular Hospital – Fort Worth continue to treat a large volume of patients and have grown in their regional reputation for clinical quality and good outcomes . PCI continues to be the favored treatment option for patients with simple and complex ischemic cardiovascular disease . Through advanced equipment and broad complement of stents available including the availability of the smallest drug-eluting stent at 2 mm , interventional cardiologists on the medical staff have worked closely with hospital leadership and outlying physicians thereby resulting in more than an overall 20 percent growth in fiscal year 2018 for volumes on the Fort Worth campus .
The Corindus ® Vascular Robotics CorPath System is the first and only FDA-cleared medical device to bring robotic precision to coronary angioplasty procedures . The system is one of less than 10 in the state of Texas and the only one in Tarrant County in fiscal year 2018 .
PCI 541
Diagnostic
Chest Pain Center – Cycle V Chest Pain Center Accreditation in Fort Worth
1,080
0 200 400 600 800 1000 1200
Total Transradial Approach 25 %
For patients who experience an ST-segment elevation myocardial infarction ( STEMI ), every minute counts . The campus at Fort Worth has programs in place that provide urgent access to the cardiac catheterization labs . The center has achieved and exceeded the national goal of an open artery within 90 minutes of arrival to the facility . Baylor Scott & White All Saints Medical Center - Fort Worth again earned Cycle V Chest Pain Center Accreditation from the Society of Cardiovascular Patient Care . It is the highest designation for heart attack care , and recognizes Baylor Scott & White – Fort Worth for using best care practices that allow clinicians to reduce time to treatment during the critical early stages of a heart attack .
Percutaneous Coronary Intervention **
U . S . 90th Percentile
BSWHVH- Fort Worth
In-hospital risk : Standardized bleeding ( all patients – rate ) 1.72 0.74 Better
Composite : Proportion of PCI patients with death , emergency CABG , stroke or repeat target vessel revascularization
Composite : Discharge medications in eligible PCI patients — aspirin , P2Y12 inhibitor and statin at discharge following PCI in eligible patients
1.05 % 0.17 % Better
96.6 % 99.4 % Better Proportion of PCI procedures with post-procedure stroke 0.00 % 0.00 % Better Percent total with any adverse events 7.3 % 1.4 % Better Angiotensin converting enzyme ( ACE ) inhibitors 44.9 % 46.0 % Better ACE or ARB among patients with EF < 40 % 78.7 % 88.0 % Better Same day discharge after elective PCI 23.3 % 29.7 % Better PCI length of stay 2.2 days < 1 day Better
** Cath PCI Registry – NCDR - through Q1 2018